Low incidence of invasive fungal infections in a large observational cohort of patients initiating IL-17 or IL-23 inhibitor therapy, United States, 2016-2022.
J Am Acad Dermatol
; 91(1): 119-122, 2024 Jul.
Article
em En
| MEDLINE
| ID: mdl-38462134
Palavras-chave
Candida infection; Crohn's disease; blastomycosis; brodalumab; candidiasis; coccidioidomycosis; esophageal candidiasis; guselkumab; histoplasmosis; inflammatory bowel disease; interleukin-17 inhibitors; interleukin-23 inhibitors; invasive fungal infection; ixekizumab; psoriasis; risankizumab; secukinumab; tildrakizumab; ustekinumab
Texto completo:
1
Base de dados:
MEDLINE
Assunto principal:
Psoríase
/
Interleucina-17
/
Interleucina-23
/
Infecções Fúngicas Invasivas
Limite:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
País/Região como assunto:
America do norte
Idioma:
En
Revista:
J Am Acad Dermatol
Ano de publicação:
2024
Tipo de documento:
Article